마이크로니들 약물전달 시스템 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2033년)

Microneedle Drug Delivery Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,227,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,555,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,291,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 세계 마이크로니들 약물전달 시스템 시장에 대한 상세한 조사 보고서를 발표했습니다. 이 보고서는 시장 동인, 동향, 기회, 과제 등 주요 시장 역학에 대한 상세한 분석을 통해 시장 구조에 대한 종합적인 통찰력을 제공합니다.

주요 인사이트

• 마이크로니들 약물전달 시스템 시장 규모(2024년) : 67억 달러
• 2033년 예상 시장 가치: 108억 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 5.4%

마이크로니들 약물전달 시스템 시장 - 조사 범위 :

마이크로니들 약물전달 시스템 시장에는 마이크로니들을 사용하여 피부를 통해 통증 없이 효과적으로 약물을 전달하도록 설계된 다양한 기술들이 포함됩니다. 이 시장에는 경피 약물전달 및 백신 접종에 중요한 역할을 하는 고체 마이크로니들, 중공 마이크로니들, 용해성 마이크로니들 등 다양한 유형의 마이크로니들 장치가 포함됩니다. 시장은 의약품, 화장품, 진단 등 다양한 분야에 서비스를 제공하며 소매점, 병원, 클리닉을 통해 유통되고 있습니다. 약물전달은 최소 침습적 약물전달 방법에 대한 소비자의 관심 증가, 무통 투여에 대한 인식 증가, 약물 자가 투여 경향 증가가 성장의 원동력이 되고 있습니다.

시장 성장의 촉진요인:

세계 마이크로니들 약물전달 시스템 시장을 이끄는 몇 가지 주요 요인은 다음과 같습니다. 만성 질환 증가, 효과적인 약물전달 시스템에 대한 요구는 마이크로니들 기술에 대한 수요를 증가시키고 있습니다. 마이크로니들 설계 및 재료의 기술 발전으로 성능과 신뢰성이 향상되어 시장 확대에 박차를 가하고 있습니다. 또한, 셀프 메디케이션과 재택치료 증가 추세는 사용자 친화적이고 비침습적인 약물전달 시스템에 대한 수요를 촉진하고 있습니다. 가처분 소득 증가와 프리미엄 헬스케어 솔루션에 대한 관심도 시장 확대에 기여하고 있습니다.

시장 성장 억제요인 :

마이크로니들 약물전달 시스템 시장은 유망한 성장 전망에도 불구하고, 첨단 마이크로니들 시스템의 높은 비용과 원자재 가격 변동에 따른 어려움에 직면해 있습니다. 또한, 규제 장벽과 진화하는 소비자 선호도에 대응하기 위한 지속적인 기술 혁신의 필요성도 영향을 미치고 있습니다. 또한, 저가 대체품을 제공하는 수많은 현지 기업 및 비조직 기업의 존재로 인해 기존 브랜드 시장 점유율이 제한될 수 있습니다. 이러한 문제를 해결하고 경쟁력을 유지하기 위해서는 효과적인 공급망 관리, 경쟁력 있는 가격 책정, 연구개발에 대한 지속적인 투자가 필요합니다.

시장 기회 :

맞춤형 의료와 약물전달 증가 추세는 이 시장에 큰 기회를 제공합니다. 고효율, 친환경 마이크로니들 시스템의 개발은 지속 가능하고 첨단 의료 기술에 대한 수요 증가에 대응하고, 전자상거래 플랫폼의 확장은 시장 성장을 위한 새로운 채널을 제공하여 기업이 더 많은 사람들에게 다가갈 수 있는 기회를 제공합니다. 도시화의 진전과 건강 지향적 소비자 수 증가는 고품질 마이크로니들 시스템에 대한 수요를 촉진하고 있습니다. 전략적 파트너십, 신기술에 대한 투자, 혁신적인 약물전달 솔루션의 도입은 새로운 기회를 활용하고 시장 리더십을 유지하는 데 필수적입니다.

본 보고서에서 다룬 주요 질문들

• 마이크로니들 약물전달 시스템 시장의 세계 성장을 가속하는 주요 요인은?
• 마이크로니들 약물전달 시스템 채택을 주도하고 있는 마이크로니들 유형과 적용 분야는?
• 기술 발전은 마이크로니들 약물전달 시스템 시장 경쟁 구도에 어떤 영향을 미치고 있는가?
• 마이크로니들 약물전달 시스템 시장의 주요 기업은 누구이며, 경쟁력을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 마이크로니들 약물전달 시스템 시장의 새로운 트렌드와 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한

제3장 시장 리스크와 동향 평가

• 리스크 평가
  • COVID-19 위기와 마이크로니들 약물전달 시스템 시장에 대한 영향
  • 과거 위기와 비교한 COVID-19의 영향 벤치마크
  • 시장 매출에 대한 영향(금액)
  • 주요 국가별 평가
  • 주요 시장 부문별 평가
  • 공급업체를 위한 행동 포인트와 추천 사항
• 시장에 영향을 미치는 주요 동향
• 처방과 제품 개발 동향

제4장 시장 배경

• 마이크로니들 약물전달 시스템 시장, 주요 국가별
• 마이크로니들 약물전달 시스템 시장 기회 평가(금액)
• 시장 시나리오 예측
• 투자 실현 가능성 분석
• 예측 요인 - 관련성과 영향
• 시장 역학

제5장 중요 성공 요인

제6장 세계 시장 수요 분석

• 시장 분석, 2019년-2023년
• 시장 예측, 2024년-2033년
• 전년대비 성장 동향 분석

제7장 세계 시장 가치 분석

• 시장 분석, 2019년-2023년(금액)
• 시장 예측, 2024년-2033년(금액)
  • 전년대비 성장 동향 분석
  • 절대적 매출 기회

제8장 유형별 : 세계 시장 분석

• 서론/주요 조사 결과
• 시장 규모 분석, 2019년-2023년(금액)
• 시장 규모 분석과 예측, 2024-2033년(금액)
  • 고체
  • 중공
  • 용해
  • 코팅
  • 기타
• 시장의 매력 분석

제9장 재료별 : 세계 시장 분석

• 서론/주요 조사 결과
• 시장 규모 분석, 2019년-2023년(금액)
• 시장 규모 분석과 예측, 2024-2033년(금액)
  • 실리콘
  • 금속
  • 폴리머
  • 기타
• 시장의 매력 분석

제10장 용도별 : 세계 시장 분석

• 서론/주요 조사 결과
• 시장 규모 분석, 2019년-2023년(금액)
• 시장 규모 분석과 예측, 2024-2033년(금액)
  • 피부과
  • 약물전달
  • 통증 관리
  • 암 치료
  • 백신전달
  • 기타
• 시장의 매력 분석

제11장 지역별 : 시장 분석

• 서론
• 시장 규모 분석, 2019년-2023년(금액)
• 시장 규모 분석과 예측, 2024-2033년(금액)
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카(중동 및 아프리카)
• 시장의 매력 분석

제12장 북미의 마이크로니들 약물전달 시스템 시장 분석

제13장 라틴아메리카의 마이크로니들 약물전달 시스템 시장 분석

제14장 유럽의 마이크로니들 약물전달 시스템 시장 분석

제15장 아시아태평양의 마이크로니들 약물전달 시스템 시장 분석

제16장 중동 및 아프리카의 마이크로니들 약물전달 시스템 시장 분석

제17장 주요 국가의 마이크로니들 약물전달 시스템 시장 분석

• 서론
  • 주요 국가별 시장 매출 비율 분석
  • 세계와 국가별 성장 비교
• 미국
• 캐나다
• 멕시코
• 브라질
• 독일
• 프랑스
• 이탈리아
• 인도
• 영국
• 호주
• 중국
• 일본
• 한국
• 이스라엘
• 남아프리카공화국
• 아랍에미리트(UAE)
• 스페인
• 러시아
• 사우디아라비아
• 국내 경쟁 구도와 기업-집중도

제18장 시장 구조 분석

• 기업 Tier별 시장 분석
• 시장 집중
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제19장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁 상세
  • Raphas Co. Ltd.
  • Becton Dickinson and Company
  • NanoPass Technologies Limited
  • 3M
  • Zosano Pharma Corporation
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab

제20장 사용된 전제조건과 두자어

제21장 조사 방법

LSH

영문 목차

영문목차

Persistence Market Research has recently published a detailed report on the global Microneedle Drug Delivery Systems market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.

Key Insights:

• Microneedle Drug Delivery Systems Market Size (2024E): USD 6.7 Bn
• Projected Market Value (2033F): USD 10.8 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 5.4%

Microneedle Drug Delivery Systems Market - Report Scope:

The Microneedle Drug Delivery Systems market encompasses a range of technologies designed to deliver drugs painlessly and effectively through the skin using microneedles. This market includes various types of microneedle devices such as solid microneedles, hollow microneedles, and dissolving microneedles, which are crucial for transdermal drug delivery and vaccination. The market serves different segments, including pharmaceuticals, cosmetics, and diagnostics, distributed through retail, hospitals, and clinics. Growth is driven by increasing consumer interest in minimally invasive drug delivery methods, rising awareness about pain-free administration, and the growing trend of self-administration of drugs.

Market Growth Drivers:

Several key factors drive the global Microneedle Drug Delivery Systems market. The rising prevalence of chronic diseases and the need for effective drug delivery systems boost demand for microneedle technologies. Technological advancements in microneedle design and materials enhance performance and reliability, fueling market expansion. Additionally, the growing trend of self-medication and home healthcare drives the demand for user-friendly and non-invasive drug delivery systems. Increased disposable income and a focus on premium healthcare solutions also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the Microneedle Drug Delivery Systems market faces challenges related to the high cost of advanced microneedle systems and fluctuating raw material prices. The market is also impacted by regulatory hurdles and the need for continuous innovation to meet evolving consumer preferences. Furthermore, the market is influenced by the presence of numerous local and unorganized players offering lower-cost alternatives, which can limit market share for established brands. Effective supply chain management, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.

Market Opportunities:

The market presents significant opportunities driven by the rising trend of personalized medicine and targeted drug delivery. The development of high-efficiency and eco-friendly microneedle systems caters to the growing demand for sustainable and advanced healthcare technologies. The expansion of e-commerce platforms provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious consumers drive the demand for high-quality microneedle systems. Strategic partnerships, investments in new technologies, and the introduction of innovative drug delivery solutions are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Microneedle Drug Delivery Systems market globally?
• Which microneedle types and application areas are leading the adoption of microneedle drug delivery systems?
• How are technological advancements influencing the competitive landscape of the Microneedle Drug Delivery Systems market?
• Who are the key players in the Microneedle Drug Delivery Systems market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Microneedle Drug Delivery Systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Microneedle Drug Delivery Systems market, including 3M, Becton Dickinson and Company, and Zosano Pharma Corporation, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced microneedle technologies, such as dissolvable microneedles and integrated microneedle patches. Collaborations with pharmaceutical companies, research institutions, and online platforms facilitate market access and promote new product adoption. Emphasis on sustainable manufacturing processes, high-performance materials, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Microneedle Drug Delivery Systems landscape.

Key Companies Profiled:

• Raphas Co. Ltd.
• Becton Dickinson and Company
• NanoPass Technologies Limited
• 3M
• Zosano Pharma Corporation
• Corium International Inc.
• Valeritas Inc.
• Nitto Denko Corporation
• Microdermics Inc.
• TheraJect Inc.
• Vaxxas Pty Ltd.
• Endoderma Ltd.
• QuadMedicine
• SNvia Co. Ltd.
• Small Lab

Microneedle Drug Delivery Systems Market Industry Segmentation

By Type

• Solid
• Hollow
• Dissolving
• Coated
• Other Types

By Material

• Silicon
• Metal
• Polymer
• Other Materials

By Application

• Dermatology
• Drug Delivery
• Pain Management
• Cancer Therapy
• Vaccine Delivery
• Other Applications

By Region

• North America
• Latin America
• Europe
• APAC
• MEA

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Summary of Statistics
• 1.3. Key Market Characteristics & Attributes
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

• 3.1. Risk Assessment
  • 3.1.1. COVID-19 Crisis and Impact on Microneedle Drug Delivery Systems Market
  • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
  • 3.1.3. Impact on Market Value (US$ Bn)
  • 3.1.4. Assessment by Key Countries
  • 3.1.5. Assessment by Key Market Segments
  • 3.1.6. Action Points and Recommendation for Suppliers
• 3.2. Key Trends Impacting the Market
• 3.3. Formulation and Product Development Trends

4. Market Background

• 4.1. Microneedle Drug Delivery Systems Market, by Key Countries
• 4.2. Microneedle Drug Delivery Systems Market Opportunity Assessment (US$ Bn)
  • 4.2.1. Total Available Market
  • 4.2.2. Serviceable Addressable Market
  • 4.2.3. Serviceable Obtainable Market
• 4.3. Market Scenario Forecast
  • 4.3.1. Demand in optimistic Scenario
  • 4.3.2. Demand in Likely Scenario
  • 4.3.3. Demand in Conservative Scenario
• 4.4. Investment Feasibility Analysis
  • 4.4.1. Investment in Established Markets
    • 4.4.1.1. In Short Term
    • 4.4.1.2. In Long Term
  • 4.4.2. Investment in Emerging Markets
    • 4.4.2.1. In Short Term
    • 4.4.2.2. In Long Term
• 4.5. Forecast Factors - Relevance & Impact
  • 4.5.1. Top Companies Historical Growth
  • 4.5.2. Growth in Automation, By Country
  • 4.5.3. Microneedle Drug Delivery Systems Markets Adoption Rate, By Country
• 4.6. Market Dynamics
  • 4.6.1. Market Driving Factors and Impact Assessment
  • 4.6.2. Prominent Market Challenges and Impact Assessment
  • 4.6.3. Microneedle Drug Delivery Systems Markets Market Opportunities
  • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

• 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
• 5.2. Banking on with Segments High Incremental Opportunity
• 5.3. Peer Benchmarking

6. Global Microneedle Drug Delivery Systems Market Demand Analysis 2019-2023 and Forecast, 2024-2033

• 6.1. Historical Market Analysis, 2019-2023
• 6.2. Current and Future Market Projections, 2024-2033
• 6.3. Y-o-Y Growth Trend Analysis

7. Global Microneedle Drug Delivery Systems Market Value Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Type

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis By Type, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type, 2024-2033
  • 8.3.1. Solid
  • 8.3.2. Hollow
  • 8.3.3. Dissolving
  • 8.3.4. Coated
  • 8.3.5. Other Types
• 8.4. Market Attractiveness Analysis By Microneedle Drug Delivery Systems

9. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Material

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis By Material, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Material, 2024-2033
  • 9.3.1. Silicon
  • 9.3.2. Metal
  • 9.3.3. Polymer
  • 9.3.4. Other Materiales
• 9.4. Market Attractiveness Analysis By Application

10. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
  • 10.3.1. Dermatology
  • 10.3.2. Drug Delivery
  • 10.3.3. Pain Management
  • 10.3.4. Cancer Therapy
  • 10.3.5. Vaccine Delivery
  • 10.3.6. Other Applications
• 10.4. Market Attractiveness Analysis By Application

11. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 11.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. Asia Pacific
  • 11.3.5. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Pricing Analysis
• 12.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 12.4.1. By Country
    • 12.4.1.1. U.S.
    • 12.4.1.2. Canada
  • 12.4.2. By Type
  • 12.4.3. By Application
  • 12.4.4. By Application
• 12.5. Market Attractiveness Analysis
  • 12.5.1. By Country
  • 12.5.2. By Material
  • 12.5.3. By Application
  • 12.5.4. By Application

13. Latin America Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Pricing Analysis
• 13.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 13.4.1. By Country
    • 13.4.1.1. Brazil
    • 13.4.1.2. Mexico
    • 13.4.1.3. Rest of Latin America
  • 13.4.2. By Type
  • 13.4.3. By Application
  • 13.4.4. By Application
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Country
  • 13.5.2. By Material
  • 13.5.3. By Application
  • 13.5.4. By Application

14. Europe Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Pricing Analysis
• 14.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 14.4.1. By Country
    • 14.4.1.1. Germany
    • 14.4.1.2. France
    • 14.4.1.3. U.K.
    • 14.4.1.4. Italy
    • 14.4.1.5. Spain
    • 14.4.1.6. Russia
    • 14.4.1.7. Rest of Europe
  • 14.4.2. By Type
  • 14.4.3. By Application
  • 14.4.4. By Application
• 14.5. Market Attractiveness Analysis
  • 14.5.1. By Country
  • 14.5.2. By Material
  • 14.5.3. By Application
  • 14.5.4. By Application

15. Asia Pacific Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Pricing Analysis
• 15.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 15.4.1. By Country
    • 15.4.1.1. China
    • 15.4.1.2. Japan
    • 15.4.1.3. South Korea
    • 15.4.1.4. India
    • 15.4.1.5. Australia
    • 15.4.1.6. Rest of Asia Pacific
  • 15.4.2. By Type
  • 15.4.3. By Application
  • 15.4.4. By Application
• 15.5. Market Attractiveness Analysis
  • 15.5.1. By Country
  • 15.5.2. By Material
  • 15.5.3. By Application
  • 15.5.4. By Application

16. Middle East and Africa Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Pricing Analysis
• 16.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 16.4.1. By Country
    • 16.4.1.1. Saudi Arabia
    • 16.4.1.2. South Africa
    • 16.4.1.3. Israel
    • 16.4.1.4. UAE
    • 16.4.1.5. Rest of Middle East and Africa
  • 16.4.2. By Type
  • 16.4.3. By Application
  • 16.4.4. By Application
• 16.5. Market Attractiveness Analysis
  • 16.5.1. By Country
  • 16.5.2. By Material
  • 16.5.3. By Application
  • 16.5.4. By Application

17. Key Countries Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
  • 17.1.1. Market Value Proportion Analysis, By Key Countries
  • 17.1.2. Global Vs. Country Growth Comparison
• 17.2. US Microneedle Drug Delivery Systems Market Analysis
  • 17.2.1. Value Proportion Analysis by Market Taxonomy
  • 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.2.2.1. By Type
    • 17.2.2.2. By Application
    • 17.2.2.3. By Application
• 17.3. Canada Microneedle Drug Delivery Systems Market Analysis
  • 17.3.1. Value Proportion Analysis by Market Taxonomy
  • 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.3.2.1. By Material
    • 17.3.2.2. By Application
    • 17.3.2.3. By Application
• 17.4. Mexico Microneedle Drug Delivery Systems Market Analysis
  • 17.4.1. Value Proportion Analysis by Market Taxonomy
  • 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.4.2.1. By Type
    • 17.4.2.2. By Application
    • 17.4.2.3. By Application
• 17.5. Brazil Microneedle Drug Delivery Systems Market Analysis
  • 17.5.1. Value Proportion Analysis by Market Taxonomy
  • 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.5.2.1. By Material
    • 17.5.2.2. By Application
    • 17.5.2.3. By Application
• 17.6. Germany Microneedle Drug Delivery Systems Market Analysis
  • 17.6.1. Value Proportion Analysis by Market Taxonomy
  • 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.6.2.1. By Type
    • 17.6.2.2. By Application
    • 17.6.2.3. By Application
• 17.7. France Microneedle Drug Delivery Systems Market Analysis
  • 17.7.1. Value Proportion Analysis by Market Taxonomy
  • 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.7.2.1. By Type
    • 17.7.2.2. By Application
    • 17.7.2.3. By Application
• 17.8. Italy Microneedle Drug Delivery Systems Market Analysis
  • 17.8.1. Value Proportion Analysis by Market Taxonomy
  • 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.8.2.1. By Type
    • 17.8.2.2. By Application
    • 17.8.2.3. By Application
• 17.9. India Microneedle Drug Delivery Systems Market Analysis
  • 17.9.1. Value Proportion Analysis by Market Taxonomy
  • 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.9.2.1. By Type
    • 17.9.2.2. By Application
    • 17.9.2.3. By Application
• 17.10. UK Microneedle Drug Delivery Systems Market Analysis
  • 17.10.1. Value Proportion Analysis by Market Taxonomy
  • 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.10.2.1. By Material
    • 17.10.2.2. By Application
    • 17.10.2.3. By Application
• 17.11. Australia Microneedle Drug Delivery Systems Market Analysis
  • 17.11.1. Value Proportion Analysis by Market Taxonomy
  • 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.11.2.1. By Type
    • 17.11.2.2. By Application
    • 17.11.2.3. By Application
• 17.12. China Microneedle Drug Delivery Systems Market Analysis
  • 17.12.1. Value Proportion Analysis by Market Taxonomy
  • 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.12.2.1. By Type
    • 17.12.2.2. By Application
    • 17.12.2.3. By Application
• 17.13. Japan Microneedle Drug Delivery Systems Market Analysis
  • 17.13.1. Value Proportion Analysis by Market Taxonomy
  • 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.13.2.1. By Type
    • 17.13.2.2. By Application
    • 17.13.2.3. By Application
• 17.14. South Korea Microneedle Drug Delivery Systems Market Analysis
  • 17.14.1. Value Proportion Analysis by Market Taxonomy
  • 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.14.2.1. By Type
    • 17.14.2.2. By Application
    • 17.14.2.3. By Application
• 17.15. Israel Microneedle Drug Delivery Systems Market Analysis
  • 17.15.1. Value Proportion Analysis by Market Taxonomy
  • 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.15.2.1. By Type
    • 17.15.2.2. By Application
    • 17.15.2.3. By Application
• 17.16. South Africa Microneedle Drug Delivery Systems Market Analysis
  • 17.16.1. Value Proportion Analysis by Market Taxonomy
  • 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.16.2.1. By Type
    • 17.16.2.2. By Application
    • 17.16.2.3. By Application
• 17.17. UAE Microneedle Drug Delivery Systems Market Analysis
  • 17.17.1. Value Proportion Analysis by Market Taxonomy
  • 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.17.2.1. By Type
    • 17.17.2.2. By Application
    • 17.17.2.3. By Application
• 17.18. Spain Microneedle Drug Delivery Systems Market Analysis
  • 17.18.1. Value Proportion Analysis by Market Taxonomy
  • 17.18.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.18.2.1. By Type
    • 17.18.2.2. By Application
    • 17.18.2.3. By Application
• 17.19. Russia Microneedle Drug Delivery Systems Market Analysis
  • 17.19.1. Value Proportion Analysis by Market Taxonomy
  • 17.19.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.19.2.1. By Type
    • 17.19.2.2. By Application
    • 17.19.2.3. By Application
• 17.20. Saudi Arabia Microneedle Drug Delivery Systems Market Analysis
  • 17.20.1. Value Proportion Analysis by Market Taxonomy
  • 17.20.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.20.2.1. By Type
    • 17.20.2.2. By Application
    • 17.20.2.3. By Application
• 17.21. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

• 18.1. Market Analysis by Tier of Companies
• 18.2. Market Concentration
• 18.3. Market Share Analysis of Top Players
• 18.4. Market Presence Analysis
  • 18.4.1. By Regional footprint of Players
  • 18.4.2. Product footprint by Players

19. Competition Analysis

• 19.1. Competition Dashboard
• 19.2. Competition Benchmarking
• 19.3. Competition Deep Dive
  • 19.3.1. Raphas Co. Ltd.
    • 19.3.1.1. Overview
    • 19.3.1.2. Product Portfolio
    • 19.3.1.3. Sales Footprint
    • 19.3.1.4. Strategy Overview
  • 19.3.2. Becton Dickinson and Company
    • 19.3.2.1. Overview
    • 19.3.2.2. Product Portfolio
    • 19.3.2.3. Sales Footprint
    • 19.3.2.4. Strategy Overview
  • 19.3.3. NanoPass Technologies Limited
    • 19.3.3.1. Overview
    • 19.3.3.2. Product Portfolio
    • 19.3.3.3. Sales Footprint
    • 19.3.3.4. Strategy Overview
  • 19.3.4. 3M
    • 19.3.4.1. Overview
    • 19.3.4.2. Product Portfolio
    • 19.3.4.3. Sales Footprint
    • 19.3.4.4. Strategy Overview
  • 19.3.5. Zosano Pharma Corporation
    • 19.3.5.1. Overview
    • 19.3.5.2. Product Portfolio
    • 19.3.5.3. Sales Footprint
    • 19.3.5.4. Strategy Overview
  • 19.3.6. Corium International Inc.
    • 19.3.6.1. Overview
    • 19.3.6.2. Product Portfolio
    • 19.3.6.3. Sales Footprint
    • 19.3.6.4. Strategy Overview
  • 19.3.7. Valeritas Inc.
    • 19.3.7.1. Overview
    • 19.3.7.2. Product Portfolio
    • 19.3.7.3. Sales Footprint
    • 19.3.7.4. Strategy Overview
  • 19.3.8. Nitto Denko Corporation
    • 19.3.8.1. Overview
    • 19.3.8.2. Product Portfolio
    • 19.3.8.3. Sales Footprint
    • 19.3.8.4. Strategy Overview
  • 19.3.9. Microdermics Inc.
    • 19.3.9.1. Overview
    • 19.3.9.2. Product Portfolio
    • 19.3.9.3. Sales Footprint
    • 19.3.9.4. Strategy Overview
  • 19.3.10. TheraJect Inc.
    • 19.3.10.1. Overview
    • 19.3.10.2. Product Portfolio
    • 19.3.10.3. Sales Footprint
    • 19.3.10.4. Strategy Overview
  • 19.3.11. Vaxxas Pty Ltd.
    • 19.3.11.1. Overview
    • 19.3.11.2. Product Portfolio
    • 19.3.11.3. Sales Footprint
    • 19.3.11.4. Strategy Overview
  • 19.3.12. Endoderma Ltd.
    • 19.3.12.1. Overview
    • 19.3.12.2. Product Portfolio
    • 19.3.12.3. Sales Footprint
    • 19.3.12.4. Strategy Overview
  • 19.3.13. QuadMedicine
    • 19.3.13.1. Overview
    • 19.3.13.2. Product Portfolio
    • 19.3.13.3. Sales Footprint
    • 19.3.13.4. Strategy Overview
  • 19.3.14. SNvia Co. Ltd.
    • 19.3.14.1. Overview
    • 19.3.14.2. Product Portfolio
    • 19.3.14.3. Sales Footprint
    • 19.3.14.4. Strategy Overview
  • 19.3.15. Small Lab
    • 19.3.15.1. Overview
    • 19.3.15.2. Product Portfolio
    • 19.3.15.3. Sales Footprint
    • 19.3.15.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

관련자료